CN113313526A - Full-flow medicine price linkage monitoring system and intelligent system implementation method - Google Patents
Full-flow medicine price linkage monitoring system and intelligent system implementation method Download PDFInfo
- Publication number
- CN113313526A CN113313526A CN202110631972.0A CN202110631972A CN113313526A CN 113313526 A CN113313526 A CN 113313526A CN 202110631972 A CN202110631972 A CN 202110631972A CN 113313526 A CN113313526 A CN 113313526A
- Authority
- CN
- China
- Prior art keywords
- price
- linkage
- medicine
- data
- module
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 169
- 238000000034 method Methods 0.000 title claims abstract description 29
- 238000012544 monitoring process Methods 0.000 title claims abstract description 20
- 229940079593 drug Drugs 0.000 claims abstract description 70
- 238000004519 manufacturing process Methods 0.000 claims abstract description 54
- 230000009467 reduction Effects 0.000 claims abstract description 25
- 230000000977 initiatory effect Effects 0.000 claims abstract description 4
- 238000012790 confirmation Methods 0.000 claims description 19
- 238000007726 management method Methods 0.000 claims description 16
- 238000012550 audit Methods 0.000 claims description 9
- 238000004364 calculation method Methods 0.000 claims description 9
- 238000012795 verification Methods 0.000 claims description 9
- 230000001174 ascending effect Effects 0.000 claims description 8
- 238000005259 measurement Methods 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 7
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 238000013480 data collection Methods 0.000 claims description 6
- 238000013523 data management Methods 0.000 claims description 6
- 239000002552 dosage form Substances 0.000 claims description 6
- 230000008520 organization Effects 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 238000012545 processing Methods 0.000 claims description 5
- 230000004069 differentiation Effects 0.000 claims description 3
- 239000005022 packaging material Substances 0.000 claims description 3
- 238000012163 sequencing technique Methods 0.000 claims description 3
- 238000011161 development Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 230000003247 decreasing effect Effects 0.000 description 4
- 238000012856 packing Methods 0.000 description 2
- -1 trade name Substances 0.000 description 2
- 230000004931 aggregating effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q30/00—Commerce
- G06Q30/02—Marketing; Price estimation or determination; Fundraising
- G06Q30/0201—Market modelling; Market analysis; Collecting market data
- G06Q30/0206—Price or cost determination based on market factors
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q30/00—Commerce
- G06Q30/02—Marketing; Price estimation or determination; Fundraising
- G06Q30/0283—Price estimation or determination
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Information and communication technology [ICT] specially adapted for implementation of business processes of specific business sectors, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/26—Government or public services
Landscapes
- Business, Economics & Management (AREA)
- Development Economics (AREA)
- Engineering & Computer Science (AREA)
- Strategic Management (AREA)
- Finance (AREA)
- Accounting & Taxation (AREA)
- Marketing (AREA)
- General Physics & Mathematics (AREA)
- Entrepreneurship & Innovation (AREA)
- Economics (AREA)
- Theoretical Computer Science (AREA)
- Physics & Mathematics (AREA)
- General Business, Economics & Management (AREA)
- Tourism & Hospitality (AREA)
- Game Theory and Decision Science (AREA)
- Data Mining & Analysis (AREA)
- Educational Administration (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Human Resources & Organizations (AREA)
- Primary Health Care (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
The invention belongs to the technical field of automatic linkage systems of medicine prices, and particularly relates to a full-flow medicine price linkage monitoring system and an intelligent system implementation method, aiming at the problem of promoting the medicine operator to strengthen price self-regulation, the following scheme is proposed, wherein the full-flow medicine price linkage monitoring system comprises an automatic medicine price linkage subsystem and an automatic amplitude reduction and saved amount measuring and calculating subsystem, the automatic medicine price linkage subsystem is divided into two parts according to an initiating way, the first part is that a platform actively initiates price linkage, and the latest and effective national medicine prices can be compared with the medicines on shelves according to the service requirements and the user-defined frequency. The invention solves the problems that the platform passively receives price adjustment application of a production enterprise, actively compares the price with the national medicine price, actively initiates price linkage and promotes the price reduction of the medicine; in addition, the national medicine price data source information is corrected, so that the national medicine price information is more and more accurate; and evaluating the linkage effect of the price.
Description
Technical Field
The invention relates to the technical field of automatic drug price linkage systems, in particular to a full-flow drug price linkage monitoring system and an intelligent system implementation method.
Background
The 'lowest price linkage' is mentioned at the earliest in the guidance of the national office on the improvement of the centralized purchasing work of the medicines in the official hospitals (No. 7 in 2015 issued by the state), and then price linkage measures including provincial linkage, national left-right linkage, united body price linkage and the like are issued in succession in provinces and cities, but national uniform price linkage is not realized yet. The national medical insurance bureau mentions ' establishment of a health and security medicine price normalized supervision mechanism in the notice (No. 2019) 67 of ' opinion on the completion of current medicine price management work ' issued by the national medical insurance bureau, and promotes operators to strengthen price self-discipline.
The dynamic of the production enterprise to actively reduce the price of the medicine is insufficient, for a medicine transaction platform, the linkage of the price application of the production enterprise is too passive, and an automatic medicine price linkage system does not exist at present, so that the prices of the medicines on the shelf and the medicines in the whole country can be automatically compared, and the price linkage is actively initiated to the production enterprise.
Therefore, a full-flow medicine price linkage monitoring system and an intelligent system realization method are developed, and the system simultaneously comprises a medicine price automatic linkage subsystem and an automatic linked medicine cost saving and amplitude reduction measuring subsystem, and can simultaneously provide two price linkage ways; the platform can also manage the national medicine price data source according to the price evidence fed back by the production enterprises, and the corrected national medicine price data source is used as a data source for price linkage later, so that a virtuous circle of the data source is formed.
Meanwhile, after the price linkage, the cost of the medicine is saved and the amplitude of the medicine is reduced due to the price linkage in the medicine purchase amount can be automatically measured and calculated, and the price linkage effect is evaluated.
Disclosure of Invention
Based on the technical problem of promoting the medicine operator to strengthen the price self-discipline, the invention provides a full-process medicine price linkage monitoring system and an intelligent system implementation method.
The invention provides a full-flow medicine price linkage monitoring system and an intelligent system realization method, which comprises an automatic medicine price linkage subsystem and an automatic amplitude reduction and saved amount measuring and calculating subsystem, wherein the automatic medicine price linkage subsystem is divided into two parts according to an initiating way, the first part is that a platform actively initiates price linkage, the latest and effective national medicine price and the top-mounted medicine are compared according to a self-defined frequency by combining with business requirements, and price linkage application is carried out on a production enterprise through the platform after the price is lower than the review of the top-mounted medicine; the second part is that the production enterprise initiatively initiates price adjustment, the price is lower than the price of the drug on the shelf after the examination is passed, and the price is adjusted after the examination is passed, and the price is higher than the price of the drug on the shelf and the reporting supervision department organizes experts to conduct the adjustment after the examination is passed;
the platform actively initiates a price linkage, and comprises an M1 module, an M2 module and an M3 module, wherein the M1 module is a medicine price data collection module, the M2 module is a price comparison and price grading management module, and the M3 module is a price confirmation linkage and data management module for a production enterprise;
when a production enterprise autonomously declares price adjustment, selecting a medicine needing price adjustment of the enterprise in a system, submitting price adjustment application, auditing materials provided by the production enterprise by a platform, returning an auditing result to the production enterprise if the auditing is not passed, and submitting the application again after the production enterprise completes data according to the auditing result; and if the verification is passed, the price of the medicine with the applied price reduced is adjusted in a price adjustment filing list, the medicine with the applied price increased is reported to a supervision department organization expert for verification, and if the verification is passed, the price of the medicine on the shelf is adjusted.
Preferably, the data collection range of the M1 module is mainly divided into two parts, namely, the latest and effective national provincial bid price winning/listing price, and the business expansion urban medicine transaction price, wherein the collection frequency is once a month, and the data includes medicine information (general names, trade names, dosage forms, specifications, attributes, packaging materials, packaging specifications, conversion ratios, production enterprises and the like), price information (prices, conversion ratios, price sources and the like) and item information (province/city, platform, item name, item type, item state, item time, file name and the like).
Preferably, the M2 module automatically compares the drug on the shelf with the national drug price data, and the price of the drug on the shelf lower than the national drug price indicates that the drug is at the national low price without price linkage; and managing the price of the overhead medicines higher than the prices of other cities or platforms in the whole country according to price grading, checking the price comparison result, not performing price linkage if the price comparison result does not pass the check, generating a production enterprise price linkage confirmation letter by the system after the check is passed, and pushing the letter to the enterprise for price linkage intention confirmation.
Preferably, the price comparison in the M2 module is to compare prices of medicines with the same common name, the same dosage form, the same specification, the same production enterprise and different packaging quantities according to the "price difference rule" (issue price modification [2011] 2452), and compare prices after comparing prices of different medicines with different dimensions according to the "price difference rule", in combination with actual business requirements.
Preferably, the price grading management in the M2 module is to grade the price according to the sales size, the decreasing rate and the business scope of the product, and the "sales size" grading is to grade the medicine according to the position of the purchase amount of the medicine on the platform in the total amount, such as: the method comprises the following steps that medicines which account for 60% of the total purchase amount are preset to be in A level, medicines which account for 60% -80% of the total purchase amount are preset to be in B level, medicines which account for 80% -90% of the total purchase amount are preset to be in C level, medicines of other purchase scales are preset to be in D level, and the amplitude reduction grading is classified according to the price amplitude reduction range of price comparison between platform medicines and national medicines and the product quantity corresponding to the range, for example: the method comprises the steps of dividing the descending amplitude into four intervals, namely (+ ∞, 30% ], (30%, 10% ], (10%, 1% ], and (1%, 0), wherein the descending amplitude is (national drug price/platform drug price-1) × 100%, "business range" classification is the price differentiation according to whether a lower price source is a business expansion city or a non-business expansion city, determining the important emergency state of price linkage according to price classification management and pushing data, and pushing the pushed price comparison result to a production enterprise after auditing, and meanwhile, the price classification management can be dynamically adjusted according to business development and requirements.
Preferably, the production enterprises in the M3 module perform linkage intention confirmation according to the pushed price linkage data, the data that the enterprises do not respond to is finally brought into data source management, if the responding production enterprises agree to price linkage, a price linkage confirmation letter is generated, and the enterprises perform price adjustment after confirmation; if the enterprise does not agree with the price linkage, complaint can be initiated, the platform carries out audit, the complaint material does not accord with the requirement, and the national price data source data management is carried out on data which passes the audit and has 'the reason of no linkage' including 'price unexecuted, unconfirmed, not winning the bid price', 'non-supply, not responding', 'data error or invalid' and other types; generating a price linkage confirmation letter for the approved and adjusted other prices according to the intentions, and performing price adjustment after the enterprise confirms; and managing the included data sources which do not pass the audit.
Preferably, the measurement principle of the automatic frame reduction and saved money measurement subsystem is as follows: arranging the actual purchase data of the medicines, wherein the actual purchase data of the medicines correspond to the same city, the same product, different purchase prices and the purchase quantity corresponding to the prices according to the ascending order of the time when the prices appear for the first time.
The drug cost saved due to price linkage is the difference between the price before price linkage multiplied by the purchase quantity corresponding to the price after price linkage and the price after price linkage multiplied by the purchase quantity corresponding to the price;
the calculation formula of the saved amount is as follows:
Sa＝P1*Q2–P2*Q2+P2*Q3–P3*Q3+……+Pn-1*Qn–Pn*Qn(1)
wherein Sa represents the saved amount of price linkage, P represents the purchase price, Q represents the purchase quantity, and 1, 2, 3 and n represent ascending sequencing of purchase dates.
The formula for the amplitude reduction calculation is as follows:
R＝S1/(S1+Sa)*100％-100％(2)
wherein, R represents the price reduction amplitude, S1 represents the actual purchase amount of the medicine, and Sa represents the saved amount of the price linkage.
Preferably, the data processing fixed flow of the automatic frame reduction and saved money measuring and calculating subsystem is an M4 module.
The beneficial effects of the invention are as follows:
most province price linkage is independently declared by enterprises, but the active price reduction power of production enterprises is insufficient, the price adjustment of the production enterprises is too passive when the production enterprises put forward, the automatic drug price linkage system actively compares the prices of the drugs on the shelves with the prices of the drugs in the whole country, actively initiates price linkage to the production enterprises when the prices are lower than the prices of the drugs on the shelves, classifies the reasons of non-linkage if the production enterprises do not agree with the price linkage, and corrects the price data source of the drugs in the whole country according to evidence provided by the production enterprises, so that the price data source is more and more accurate;
1. according to the national medicine price, price linkage is initiatively initiated to production enterprises, and passivity is changed into initiative, so that price down-regulation is promoted, and the medicine cost is saved;
2. if the production enterprise does not agree with the price linkage, managing national medicine price data sources according to effective evidences fed back by the production enterprise, marking and correcting unexecuted, unconfirmed prices, uncommitted supplies, unresponsive responses, data errors and other types of data, and classifying and managing the data sources according to actual business conditions;
3. the automatic frame-reducing and money-saving amount measuring and calculating system inputs order or contract data and automatically outputs the money-saving amount and frame-reducing amount, and can screen cities and time to count the money-saving amount and frame-reducing amount of orders or contracts in different cities and different linkage time.
Drawings
FIG. 1 is a flow chart of the platform initiative initiated price linkage of a full-flow drug price linkage monitoring system and an intelligent system implementation method provided by the invention;
FIG. 2 is a flow chart of the price linkage initiated by the manufacturing enterprise of the full-flow drug price linkage monitoring system and the intelligent system implementation method provided by the invention;
FIG. 3 is a data processing flow chart of an automated margin reduction and saved amount measurement subsystem of a full-flow drug price linkage monitoring system and an intelligent system implementation method provided by the invention.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments.
Referring to fig. 1-3, a full-flow medicine price linkage monitoring system and an intelligent system implementation method, including an automatic medicine price linkage subsystem and an automatic amplitude reduction and money saving calculation subsystem, characterized in that the automatic medicine price linkage subsystem is divided into two parts according to an initiating way, the first part is platform-initiated price linkage, latest and effective nationwide medicine prices and top-mounted medicines are compared according to a custom frequency by combining with actual business demands, and price linkage application is carried out on production enterprises through the platform after the price is lower than the top-mounted medicines are checked; the second part is that the production enterprise self-declares price adjustment, the price is lower than the price of the drug on the shelf after the examination is passed, and the price is adjusted after the examination is passed by the organization expert of the reporting supervision department who reports the drug on the shelf;
the platform actively initiates a price linkage, and comprises an M1 module, an M2 module and an M3 module, wherein the M1 module is a medicine price data collection module, the M2 module is a price comparison and price grading management module, and the M3 module is a price confirmation linkage and data management module for a production enterprise;
when a production enterprise needs price adjustment, selecting a medicine needing price adjustment for the enterprise in the system, submitting price adjustment application, auditing materials provided by the production enterprise by the platform, returning an auditing result to the production enterprise if the auditing is not passed, and submitting the application again after the production enterprise completes data according to the auditing result; and if the verification is passed, the price of the medicine with the applied price reduced is adjusted in a price adjustment filing list, the medicine with the applied price increased is reported to a supervision department organization expert for verification, and if the verification is passed, the price of the medicine on the shelf is adjusted.
In the invention, the data collection range of the M1 module is mainly divided into two parts, namely the latest and effective national provincial bid price winning/online pricing and the business expansion urban medicine transaction price. The collection frequency is once a month, and the data includes medicine information (common name of medicine, trade name, formulation, specification, attribute, packing material, packing specification, conversion ratio, manufacturing company, etc.), price information (price, conversion ratio, price source, etc.), and item information (province/city, platform, item name, item type, item status, item time, file name, etc.). Linkage medicine scope: all the drug on the platform.
In the invention, the M2 module automatically compares the price data of the medicine on the shelf with the national medicine price data, and the price of the medicine on the shelf lower than the national medicine price indicates that the medicine is at the national low price without price linkage; and managing the price of the overhead medicines higher than the prices of other provinces/cities or platforms in the whole country according to price grading, auditing data needing price linkage, not carrying out price linkage if the price linkage does not pass the auditing, generating a production enterprise price linkage confirmation letter by a system after the auditing is passed, and pushing the letter to the enterprise for price linkage intention confirmation.
The price comparison in the M2 module is that firstly, the medicines with the same general name, the same dosage form, the same specification, the same production enterprise and different packaging quantities are subjected to price comparison according to the price difference rule (issue price [2011] 2452), and then the price comparison is carried out, and the price comparison is carried out after the price difference of different dimensions is carried out on the prices of different medicines according to the price difference rule in combination with the actual business requirements.
The price grading management in the M2 module is to grade the price according to the sales scale, the decreasing rate and the business scope of the product, and the "sales scale" grading is to grade the medicine according to the purchase amount of the medicine on the platform at the position of the total amount, such as: the medicine which accounts for 60 percent to 80 percent of the total purchase amount is preset as the A grade, the medicine which accounts for 80 percent to 90 percent of the total purchase amount is preset as the B grade, the medicine which accounts for 80 percent to 90 percent of the total purchase amount is preset as the C grade, and the medicines with other purchase scales are preset as the D grade. The "decreasing rate" classification is a classification according to the decreasing rate range of the price compared between the platform medicine and the national medicine price and the product quantity corresponding to the range, such as: the method comprises the steps of dividing the descending amplitude into four intervals, namely (+ ∞, 30% ], (30%, 10% ], (10%, 1% ]), (1%, 0), wherein the descending amplitude is (national drug price/platform drug price-1) × 100%, "business range" grading is the price differentiation according to whether the lower price source is a business expansion city or a non-business expansion city.
Managing the price according to the sale scale, the reduction of the breadth and the service range, and pushing the price according to the price linkage grading management table, for example, as follows:
meter-price linkage grading analog meter
Note: i stands for "important urgent", II stands for "important non-urgent", and III stands for "unimportant non-urgent".
In the invention, the production enterprises in the M3 module carry out linkage intention confirmation according to the pushed price linkage data, the data which are not responded by the enterprises are finally brought into data source management, if the responding production enterprises agree to price linkage, a price linkage confirmation letter is generated, and the enterprises carry out price adjustment after confirmation; if the enterprise does not agree with the price linkage, complaint can be initiated, the platform carries out audit, the complaint material does not accord with the requirement, and the national price data source data management is carried out on data which passes the audit and has 'the reason of no linkage' including 'price unexecuted, unconfirmed, not winning the bid price', 'non-supply, not responding', 'data error or invalid' and other types; generating a price linkage confirmation letter for the approved and adjusted other prices according to the intentions, and performing price adjustment after the enterprise confirms; and managing the included data sources which do not pass the audit.
In the invention, the measurement principle of the automatic amplitude reduction and money saving measurement subsystem is as follows: arranging the actual purchase data of the medicines, wherein the actual purchase data of the medicines correspond to the same city, the same product, different purchase prices and the purchase quantity corresponding to the prices according to the ascending order of the time when the prices appear for the first time.
| City | Product coding | Purchase price | Purchase quantity | Time of purchase | Purchase time ordering |
| City A | M0003756 | 30.5 | 1560 | 2018/11/25 | 1 |
| City A | M0003756 | 25.7 | 2450 | 2019/01/23 | 2 |
| City A | M0003756 | 23 | 4678 | 2019/09/08 | 3 |
| City B | M0000594 | 175 | 200 | 2019/12/24 | 1 |
| City B | M0000594 | 152 | 473 | 2020/03/27 | 2 |
The alignment results were as follows:
note: the same product code represents the same medicine, namely the same medicine with the same common name, dosage form, specification, packaging material and manufacturing enterprise.
The drug cost saved by the price linkage is the difference between the purchase quantity corresponding to the price before the price linkage is multiplied by the price after the price linkage and the purchase quantity corresponding to the price after the price linkage is multiplied by the price.
The calculation formula of the saved amount is as follows:
Sa＝P1*Q2–P2*Q2+P2*Q3–P3*Q3+……+Pn-1*Qn–Pn*Qn (1)
wherein Sa represents the saved amount of price linkage, P represents the purchase price, Q represents the purchase quantity, and 1, 2, 3 and n represent ascending sequencing of purchase dates.
The formula for the amplitude reduction calculation is as follows:
R＝S1/(S1+Sa)*100％-100％ (2)
wherein, R represents the price reduction amplitude, S1 represents the actual purchase amount of the medicine, and Sa represents the saved amount of the price linkage.
In the invention, the data processing fixed flow of the automatic amplitude reduction and saved money measuring and calculating subsystem is an M4 module, wherein, taking three products in two cities as an example, the data processing steps of the fixed flow of the M4 module are explained as follows:
the method comprises the following steps of firstly, arranging data in ascending order according to dates by taking the dimensions of the same city, the same product and the same price;
| city | Product coding | Purchase price | Purchase quantity | Time of purchase | Sorting |
| City A | M0003756 | 23 | 4678 | 2019/09/08 | 1 |
| City A | M0003756 | 30.5 | 328 | 2018/11/25 | 1 |
| City A | M0003756 | 30.5 | 500 | 2018/12/07 | 2 |
| City A | M0003756 | 30.5 | 732 | 2019/01/15 | 3 |
| City A | M0003756 | 25.7 | 1778 | 2019/01/23 | 1 |
| City A | M0003756 | 25.7 | 672 | 2019/07/11 | 2 |
| City B | M0000594 | 152 | 200 | 2020/03/27 | 1 |
| City B | M0000594 | 152 | 273 | 2020/04/23 | 2 |
| City B | M0000594 | 175 | 37 | 2019/12/24 | 1 |
| City B | M0000594 | 175 | 163 | 2020/01/07 | 2 |
| City B | M0001564 | 37 | 417 | 2020/01/23 | 1 |
Secondly, screening the data with the sequence of '1' to obtain the date of the same city, the same product and the first occurrence of a certain purchase price;
thirdly, aggregating the purchase quantity of the same city, the same product and the same price and adding the date of the price appearing for the first time;
| city | Product coding | Purchase price | Purchase quantity | Time of purchase |
| City A | M0003756 | 23 | 4678 | 2019/09/08 |
| City A | M0003756 | 30.5 | 1560 | 2018/11/25 |
| City A | M0003756 | 25.7 | 2450 | 2019/01/23 |
| City B | M0000594 | 152 | 473 | 2020/03/27 |
| City B | M0000594 | 175 | 200 | 2019/12/24 |
| City B | M0001564 | 37 | 417 | 2020/01/23 |
Fourthly, counting the quantity of the same city and the same product with different prices;
| city | Product coding | Purchase price | Purchase quantity | Time of purchase | Amount of price |
| City A | M0003756 | 23 | 4678 | 2019/09/08 | 3 |
| City A | M0003756 | 30.5 | 1560 | 2018/11/25 | 3 |
| City A | M0003756 | 25.7 | 2450 | 2019/01/23 | 3 |
| City B | M0000594 | 152 | 473 | 2020/03/27 | 2 |
| City B | M0000594 | 175 | 200 | 2019/12/24 | 2 |
| City B | M0001564 | 37 | 417 | 2020/01/23 | 1 |
Fifthly, eliminating data without price linkage, namely data with different price quantities of 1 in the same city and the same product;
| city | Product coding | Purchase price | Purchase quantity | Time of purchase | Amount of price |
| City A | M0003756 | 23 | 4678 | 2019/09/08 | 3 |
| City A | M0003756 | 30.5 | 1560 | 2018/11/25 | 3 |
| City A | M0003756 | 25.7 | 2450 | 2019/01/23 | 3 |
| City B | M0000594 | 152 | 473 | 2020/03/27 | 2 |
| City B | M0000594 | 175 | 200 | 2019/12/24 | 2 |
Sixthly, arranging the same city and the same product in an ascending order according to the linked dates of different prices;
seventhly, calculating the price linkage to save cost and reduce amplitude;
taking the medicine coded by city A product M0003756 as an example, the cost saving is (30.5-25.7) × 2450+ (25.7-23) × 4678 ═ 24390.6 yuan, the effective order amount is 30.5 × 1560+25.7 × 2450+23 ═ 4678 ═ 218139 yuan, and the amplitude is 218139/(218139+ 24390.6)% 100% ~ 10.06%.
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be considered to be within the technical scope of the present invention, and the technical solutions and the inventive concepts thereof according to the present invention should be equivalent or changed within the scope of the present invention.
Claims (8)
1. A full-flow medicine price linkage monitoring system and an intelligent system realization method comprise an automatic medicine price linkage subsystem and an automatic amplitude reduction and saved amount measuring and calculating subsystem, and are characterized in that the automatic medicine price linkage subsystem is divided into two parts according to an initiating way, the first part is that a platform actively initiates price linkage, the latest and effective national medicine price and the top-mounted medicine can be compared according to business requirements according to a user-defined frequency, and price linkage application is carried out on a production enterprise through the platform after the price is lower than the top-mounted medicine; the second part is that the production enterprise self-declares price adjustment, the price is lower than the price of the drug on the shelf after the examination is passed, and the price is adjusted after the examination is passed by the organization expert of the reporting supervision department who reports the drug on the shelf;
the platform actively initiates a price linkage, and comprises an M1 module, an M2 module and an M3 module, wherein the M1 module is a medicine price data collection module, the M2 module is a price comparison and price grading management module, and the M3 module is a price confirmation linkage and data management module for a production enterprise;
when a production enterprise autonomously declares price adjustment, selecting a medicine needing price adjustment of the enterprise in a system, submitting price adjustment application, auditing materials provided by the production enterprise by a platform, returning an auditing result to the production enterprise if the auditing is not passed, and submitting the application again after the production enterprise completes data according to the auditing result; and if the verification is passed, the price of the medicine with the applied price reduced is adjusted in a price adjustment filing list, the medicine with the applied price increased is reported to a supervision department organization expert for verification, and if the verification is passed, the price of the medicine on the shelf is adjusted.
2. The system for linkage monitoring of the prices of medicines in the whole process and the method for realizing the intelligent system according to claim 1 are characterized in that the data collection range of the M1 module is mainly divided into two parts, wherein the first part is the latest and effective national provincial bid price/online price, the second part is the business expansion urban medicine transaction price, the collection frequency is once a month, and the data comprise medicine information (general names, trade names, dosage forms, specifications, attributes, packaging materials, packaging specifications, conversion ratios, production enterprises and the like), price information (price, conversion ratios, price sources and the like) and item information (province/city, platform, item names, item types, item states, item time, file names and the like); linkage medicine scope: all the drug on the platform.
3. The system for linkage monitoring of the price of a full-flow medicine and the method for implementing the intelligent system according to claim 1, wherein the M2 module automatically compares the drug on the shelf with national medicine price data, and the price of the drug on the shelf lower than the national medicine price indicates that the drug is at a national low price without price linkage; the price of the overhead medicines is higher than that of other cities or platforms in the whole country, price comparison results are checked according to price grading management, a production enterprise price linkage confirmation letter is generated by a system after the checking is passed, price linkage intention confirmation is pushed to the enterprise, and price linkage is not performed if the checking is not passed.
4. The system for linkage monitoring of the prices of medicines in the whole process and the method for realizing the intelligent system according to claim 3 are characterized in that the price comparison in the M2 module is performed after price difference comparison is performed on medicines with the same common name, the same dosage form, the same specification, the same production enterprise and different packaging quantities according to the "difference price rule" (issue price [2011] 2452), and price comparison is performed after price difference of different dimensions is performed on the prices of different medicines according to the "difference price rule" in combination with actual business requirements.
5. The system for monitoring the price linkage of the full-flow medicine and the method for realizing the intelligent system according to claim 1 are characterized in that the price grading management in the M2 module is used for grading and managing the price according to the sales scale, the reducing condition and the service range of the product, and the grading of the sales scale is used for grading the purchase amount of the medicine on the platform at the position of the total amount, such as: the method comprises the following steps that medicines which account for 60% of the total purchase amount are preset to be in A level, medicines which account for 60% -80% of the total purchase amount are preset to be in B level, medicines which account for 80% -90% of the total purchase amount are preset to be in C level, medicines of other purchase scales are preset to be in D level, and the amplitude reduction grading is classified according to the price amplitude reduction range of price comparison between platform medicines and national medicines and the product quantity corresponding to the range, for example: the method comprises the steps of dividing the descending amplitude into four intervals, namely (+ ∞, 30% ], (30%, 10% ], (10%, 1% ], and (1%, 0), wherein the descending amplitude is (national drug price/platform drug price-1) × 100%, "business range" classification is the price differentiation according to whether a lower price source is a business expansion city or a non-business expansion city, determining the important emergency state of price linkage according to price classification management and pushing data, and pushing the pushed price comparison result to a production enterprise after auditing, and meanwhile, the price classification management can be dynamically adjusted according to business development and requirements.
6. The system for monitoring the linkage of the prices of the medicines in the whole process and the method for realizing the intelligent system according to claim 1 are characterized in that a production enterprise in the M3 module confirms linkage intention according to pushed price linkage data, data which are not responded by the enterprise are finally brought into data source management, if the responding production enterprise agrees to price linkage, a price linkage confirmation letter is generated, and after the enterprise confirms, price adjustment is carried out; if the enterprise does not agree with the price linkage, complaint can be initiated, the platform carries out audit, the complaint material does not accord with the requirement, and the national price data source data management is carried out on data which passes the audit and has 'the reason of no linkage' including 'price unexecuted, unconfirmed, not winning the bid price', 'non-supply, not responding', 'data error or invalid' and other types; generating a price linkage confirmation letter for the approved and adjusted other prices according to the intentions, and performing price adjustment after the enterprise confirms; and managing the last inclusion data source which does not pass the audit.
7. The system for linkage monitoring of the price of a full-flow medicine and the method for realizing the intelligent system according to claim 1 are characterized in that the measurement and calculation principle of the automatic amplitude reduction and saved amount measurement and calculation subsystem is as follows: arranging the actual medicine purchasing data with the same city, the same product, different purchasing prices and the purchasing quantity corresponding to the price according to the ascending order of the time when the price appears for the first time;
the drug cost saved due to price linkage is the difference between the price before price linkage multiplied by the purchase quantity corresponding to the price after price linkage and the price after price linkage multiplied by the purchase quantity corresponding to the price;
the calculation formula of the saved amount is as follows:
Sa＝P1*Q2–P2*Q2+P2*Q3–P3*Q3+……+Pn-1*Qn–Pn*Qn (1)
wherein Sa represents the saved amount of price linkage, P represents the purchase price, Q represents the purchase quantity, and 1, 2, 3 and n represent ascending sequencing of purchase dates;
the formula for the amplitude reduction calculation is as follows:
R＝S1/(S1+Sa)*100％-100％ (2)
wherein, R represents the price reduction amplitude, S1 represents the actual purchase amount of the medicine, and Sa represents the saved amount of the price linkage.
8. The system for linkage monitoring of the price of a full-flow medicine and the method for realizing the intelligent system as claimed in claim 1, wherein the data processing fixed flow of the automatic amplitude reduction and saved amount measurement subsystem is an M4 module.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110631972.0A CN113313526A (en) | 2021-06-07 | 2021-06-07 | Full-flow medicine price linkage monitoring system and intelligent system implementation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110631972.0A CN113313526A (en) | 2021-06-07 | 2021-06-07 | Full-flow medicine price linkage monitoring system and intelligent system implementation method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113313526A true CN113313526A (en) | 2021-08-27 |
Family
ID=77378108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110631972.0A Pending CN113313526A (en) | 2021-06-07 | 2021-06-07 | Full-flow medicine price linkage monitoring system and intelligent system implementation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113313526A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113808721A (en) * | 2021-09-26 | 2021-12-17 | 广州方舟信息科技有限公司 | Intelligent supply and collection method and system for standardized drugs |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120136809A1 (en) * | 2008-08-27 | 2012-05-31 | Cannata Michael C | Method of creating a pricing schedule for use by a pricing system |
| CN109145192A (en) * | 2018-09-17 | 2019-01-04 | 珠海横琴盛达兆业科技投资有限公司 | A method of the automatic rate of exchange of drug are realized based on internet platform |
| CN111192067A (en) * | 2018-11-14 | 2020-05-22 | 珠海横琴盛达兆业科技投资有限公司 | Method for realizing intelligent reminding of store variety price fluctuation based on internet platform |
| US20200320470A1 (en) * | 2019-04-05 | 2020-10-08 | Trulla, LLC | Pharmaceutical procurement and inventory management |
| CN111784453A (en) * | 2020-06-29 | 2020-10-16 | 平安国际智慧城市科技股份有限公司 | Block chain-based cross-platform medicine collection price synchronization method and related device |
| CN112884530A (en) * | 2021-03-24 | 2021-06-01 | 深圳市全药网科技有限公司 | Method for measuring and calculating purchase price reduction amplitude and saved amount of medicine group |
-
2021
- 2021-06-07 CN CN202110631972.0A patent/CN113313526A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120136809A1 (en) * | 2008-08-27 | 2012-05-31 | Cannata Michael C | Method of creating a pricing schedule for use by a pricing system |
| CN109145192A (en) * | 2018-09-17 | 2019-01-04 | 珠海横琴盛达兆业科技投资有限公司 | A method of the automatic rate of exchange of drug are realized based on internet platform |
| CN111192067A (en) * | 2018-11-14 | 2020-05-22 | 珠海横琴盛达兆业科技投资有限公司 | Method for realizing intelligent reminding of store variety price fluctuation based on internet platform |
| US20200320470A1 (en) * | 2019-04-05 | 2020-10-08 | Trulla, LLC | Pharmaceutical procurement and inventory management |
| CN111784453A (en) * | 2020-06-29 | 2020-10-16 | 平安国际智慧城市科技股份有限公司 | Block chain-based cross-platform medicine collection price synchronization method and related device |
| CN112884530A (en) * | 2021-03-24 | 2021-06-01 | 深圳市全药网科技有限公司 | Method for measuring and calculating purchase price reduction amplitude and saved amount of medicine group |
Non-Patent Citations (2)
| Title |
|---|
| 常以: ""医疗机构补偿与药品价格联动机制研究"", 《中国优秀博硕士学位论文全文数据库（博士） 医药卫生科技辑》 * |
| 深圳市全药网药业有限公司: ""全药网GPO平台成交品种价格联动操作手册"", 《HTTPS://WWW.QUANYAOWANG.COM/PAGE/DOWNLOAD_B》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113808721A (en) * | 2021-09-26 | 2021-12-17 | 广州方舟信息科技有限公司 | Intelligent supply and collection method and system for standardized drugs |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bai et al. | The return to capital in China | |
| US20050273401A1 (en) | Cost comparing system and method | |
| Hanefah et al. | Compliance costs of small and medium enterprises | |
| CN111462886A (en) | Full life cycle real-time online management system for medical equipment | |
| CN111081361A (en) | Intelligent logistics platform management system | |
| CN104599019A (en) | Financial budgeting system | |
| CN111882386B (en) | Freight quotation method and device | |
| CN110210954A (en) | Tax administration system and method | |
| CN109447570A (en) | A kind of more industry situation wages management of computing systems of grouping of the world economy | |
| CN113313526A (en) | Full-flow medicine price linkage monitoring system and intelligent system implementation method | |
| CN114548865A (en) | Design method of production scheduling early warning and alarm mechanism system based on ERP | |
| CN111192668A (en) | Medicine auditing method | |
| CN111599453A (en) | Intelligent pharmacy data processing method and device, computer equipment and storage medium | |
| CN115237985A (en) | Investment risk index analysis platform based on ETL | |
| CN111080262A (en) | Intelligent logistics platform management method | |
| CN112712324A (en) | Actual cost accounting system and method for automobile part industry | |
| CN113361961A (en) | PDCA closed-loop management-based national collection full-process monitoring system and intelligent system implementation | |
| US20040122758A1 (en) | Budget and financial analysis system and method | |
| US20200151198A1 (en) | Method of Building Semantic Multi-dimensional Database | |
| US20040249770A1 (en) | Cost computing system and method | |
| Azadi et al. | The COVID-19 pandemic and the performance of healthcare supply chains | |
| CN110490664B (en) | Configurable minimum price control method for information system | |
| CN114092208A (en) | Enterprise tax accounting control and early warning platform | |
| CN112613960A (en) | Real estate land increment tax clearing method and system based on bill information | |
| CN111553676A (en) | Fine management system and method for funds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210827 |